Measured by its ability to inhibit anti-CD3 antibody induced IFN-gamma secretion by human peripheral blood mononuclear cells (PBMC). The ED50for this effect is 0.5-3 μg/mL.
Purity ≥95% SDS-PAGE. Endotoxin level <0.1 EU/µg Function Phagocytic receptor, strong negative regulator of T-cell proliferation and IL2 production. Potent inhibitor of the alternative complement pathway convertases.
规格
产品名称
Recombinant Human VSIG4 Protein
别名
重组人VSIG4蛋白 | 重组人 VSIG4 蛋白
英文别名
V-Set and Immunoglobulin Domain Containing 4 | CRIg | Ig superfamily protein | Protein Z39Ig | V-set and immunoglobulin domain-containing protein 4 | VSIG4 | Z39IG | complement receptor of the immunoglobulin superfamily
Measured by its ability to inhibit anti-CD3 antibody induced IFN-gamma secretion by human peripheral blood mononuclear cells (PBMC). The ED50for this effect is 0.5-3 μg/mL.
48 kDa, under reducing conditions; 48 kDa, under non-reducing conditions.
分子类型
蛋白质
产品线
生物产品
储存与运输
物理形态
冻干(Lyophilized)
储存缓冲液
Lyophilized from 10mM PBS, 5% Trehalose, 5% Mannitol, pH7.4.
复溶
Reconstitute in sterile water to a concentration of 0.1-0.5 mg/ml.
储存条件
-20°C储存,避免反复冻融
运输条件
超低温运输
稳定性与储存
在 -20~-80℃ 下可保存 1 年以上。收货后建议分装。避免冷冻/解冻循环。
图片
Recombinant Human VSIG4 Protein (rp164797) - SDS-PAGE 3 μg/lane of Recombinant Human VSIG4 Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing the band at 48 kDa. The protein has a calculated MW of 30 kDa. The protein migrates as 48 kDa under reducing (R) and non-reducing (N) conditions (SDS-PAGE) due to glycosylation.
ZJ24F1214988
危险品化学品经营许可证（带存储）